跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRIKAFTA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TRIKAFTA
Authorized
STANDARD
TRIKAFTA
Vertex Pharmaceuticals (Canada) Incorporated
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e35d63224fcf35fb
Company
Vertex Pharmaceuticals (Canada) Incorporated
Type
Standard
Approval Details
Approval Id
e35d63224fcf35fb
Drug Approval Canada Name
TRIKAFTA
Product Name
TRIKAFTA
Status
Marketed
Status Date
2023-10-27
Original Market Date
2023-10-27
Din
02542285
Drug Class
Human
Dosage Form
Granules
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:14.04
Atc Original
R07AX32 IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR
Atc Name
r 07 ax 32
Aig Number
0462989004
Company Name
Vertex Pharmaceuticals (Canada) Incorporated
Company Address
1520, 20 Bay Street, Toronto, Ontario, Canada, M5J 2N8
Active Ingredients
ELEXACAFTOR
80 MG
IVACAFTOR
59.5 MG
IVACAFTOR
60 MG
TEZACAFTOR
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e35d63224fcf35fb
Type
Standard
Back to Health Canada Approvals